Professor Henry J Dargie MB ChB, FRCP, FESC, FRSE Lifetime Achievement Award Inaugural Phillip Poole-Wilson Lecture Agora: Sunday 2th May 14:15. Young.

Slides:

Advertisements

Similar presentations

Presenter Disclosure Information

Advertisements

Heart Failure and Transplant Medicine Council Immediate Past Chair: David A. Baran, MD Chair: Lee R. Goldberg, MD, MPH Vice-Chair Elect Brad Dyke MD.

Inequalities across Europe in access to primary angioplasty to treat acute heart attack patients -the cross-border dimension- John Martin, MD, FRCP, FESC,

Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.

Optimizing Treatment Of Heart Failure for individual patients By Prof. Mansoor Ahmad FRCP Consultant Cardiologist.

Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):

Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University

Open Access Policies in Scotland and the UK Morag Greig, University of Glasgow.

Discussant Inder Anand, MD, FRCP, D Phil (Oxon.)

CM-1 ACE Inhibitor Dosing Considerations in CHARM John J.V. McMurray, MD Professor of Medical Cardiology Western Infirmary Glasgow Scotland UK.

Cardiovascular Disease Prevention in Clinical Practice – The National Coordinator Dr Siobhan Jennings, Consultant in Public Health Medicine National Coordinator.

The BHF FAMOUS NSTEMI Trial For the FAMOUS NSTEMI Investigators ESC Hotline for Myocardial Infarction, 1 Sep 2014 J. Layland, K.G. Oldroyd, N. Curzen,

The BHF FAMOUS NSTEMI Trial For the FAMOUS NSTEMI Investigators ESC Hotline for Myocardial Infarction, 1 Sep 2014 J. Layland, K.G. Oldroyd, N. Curzen,

Council on Cardiovascular Nursing and Allied Professions CCNAP.

Department of Cardiothoracic Surgery St. George’s Healthcare NHS Trust St. George’s University of London.

Dorset Improving Diagnosis of Heart Failure Implementation of BNP Measuring in General Practice Ist Project Steering Group 13 th Sept 2011.

Heart Failure Whistle Stop Talks No 1 HFrEF and HFpEF Definitions for Diagnosis Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.

Click to edit Master title style Developing a Cardiac Oncology Fellowship Program ASCO June 2014 Susan Dent Medical Oncologist The Ottawa Hospital Cancer.

Heart Failure Whistle Stop Talks No. 2 Classification Implications Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.

Mentor Champion Meeting October 16, pm 628HE CSB.

Heart Failure Ben Starnes MD FACC Interventional Cardiology

Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.

West Herts. PCT Cardiac Rehabilitation Service Cardiology Connect Meeting– Wednesday 17th September 2008 Chris Pace – Senior Cardiac Rehab. Nurse Marie-Jeanne.

RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.

Systems Council Awards Jian Sun April 4, Introduction Professor at Rensselaer Polytechnic Institute Director of New York State Center for Future.

The index of microvascular resistance measured acutely predicts infarct severity and left ventricular function at 3 months in patients with ST segment.

U.K. ROLL-OUT OF DRUG-ELUTING STENTS JIM McLENACHAN, YORKSHIRE HEART CENTRE, LEEDS. ADVANCED ANGIOPLASTY 17 th JANUARY, 2003.

Impact of ACE inhibitors and Angiotensin II receptor blockers on all- cause mortality in hypertension trials Congress of the European Society of Cardiology.

CI-1 ATACAND ® (candesartan cilexetil) Cardiovascular and Renal Drugs Advisory Committee Rockville, Maryland February 24, 2005 C.

Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.

Retirement Systems, Issues and Solutions Australia, post Cooper and the International Environment.

European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.

Russian Society of Cardiology: an example of a successful National Cardiac Society membership scheme President of the Russian Society of Cardiology Professor.

Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:

Chairman Academic and Research Committee

Half-Yearly meeting June 2016

Lothian Heart Failure Diagnostic Pathway

British Society of Cardiovascular Magnetic Resonance

Cardiac MRI for Radiographers Monday 2nd & Tuesday 3rd October 2017

Heart Failure GP teaching session 5 Dec 2016

An individual patient level analysis of double-blind randomised trials

An individual patient level analysis of double-blind randomised trials

Collegiate/Professional Section/MAL/Affiliate

Catriona Clark and Clare MacRae

Acromegalic cardiomyopathy: A case report

Promotions Process.

RAAS Blockade: Focus on ACEI

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection Derek V. Exner, MD, MPH, David.

Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)

Expert Insights on Complex Clinical Cases of Edema

Time after discharge (days)

Nat. Rev. Cardiol. doi: /nrcardio

Section III: Neurohormonal strategies in heart failure

The Saint Vincents Screening To Prevent Heart Failure (STOP-HF) Study

Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,

Successes and failures of current treatment of heart failure

Risk Factor Modification

Lothian Heart Failure Diagnostic Pathway

Editorial Heart Failure Clinics

Scottish Cardiac Society Autumn Meeting 30 September 2016

Primary care organisational interventions for secondary prevention of ischaemic heart disease: a systematic review and meta-analysis by Edel Murphy, Akke.

Catriona Clark and Clare MacRae

Electrocardiographic abnormalities and uremic cardiomyopathy

Diabetes research update: GGC MCN meeting 5th February 2019

Effect of sacubitril/valsartan on the rate of heart failure (HF) hospitalisations as a time to first event analysis and as a recurrent event analysis of.

β-Blocker Use for the Stages of Heart Failure

Potential protocol for the treatment of pulmonary embolism (PE), incorporating direct oral anticoagulants (OACs). Potential protocol for the treatment.

Effect of sacubitril/valsartan on the rate of primary end point and component and all-cause mortality in patients randomised in the PARADIGM-HF trial according.

Comparison of heart failure admissions rates per annum (recorded hospital admissions/ population at risk) in western developed countries 1978 to.

Presentation transcript:

Professor Henry J Dargie MB ChB, FRCP, FESC, FRSE Lifetime Achievement Award Inaugural Phillip Poole-Wilson Lecture Agora: Sunday 2th May 14:15. Young Investigator Session Consultant Cardiologist at the Western Infirmary, Glasgow, Director of the National Advanced Heart Failure Service, Glasgow ( )

Research Achievements Metolozone in renal failure and heart failure Total Body Potassium in heart and renal failure Early work on role of SNS in hypertension Early RCT work on role of captopril in HF LVH and ventricular arrhythmias Epidemiology of LV dysfunction (MRC and BHF Programme Grant holder for 10 years) Role of BNP in detection of LV dysfunction, mortality prediction MRI and cardiac remodelling Landmark Clinical Trials CIBIS II CAPRICORN IONA Numerous Other Trials TIBET Perindopril and LV remodelling MOXCON

National and International Committees Working Group for Heart Failure (ESC) now HFA Chair of WG for Exercise and Prevention (ESC) President Scottish Cardiac Society Chair of British Society for Heart Failure Chair of British Society of CMR BCS Guidelines Committee MHRA and CHM-years of service. Stokes Lecture (ICS) Fitzgerald Peel Lecture (SSP) Inaugural Philip Poole-Wilson Memorial Lecture (BSH)

British Society of Heart Failure Chair National Data Base Project UK National Clinical Audit Pioneered the concept of HF units

Academic Metrics NHS Consultant PCI until 5 years before retiral ! 339 papers in pubmed… >20,000 citations H-index 62

Research Fellows John Cleland Ian Findlay Jim McLenachan Howard McAlpine John McMurray Simon Ray David Northridge Theresa McDonagh Andrew Clark John Byrne Stephen Robb David Murdoch Nicola Johnston Tom Martin Aengus Murphy Patrick Mark* Stuart Watkins * Robin Weir Sai Bahgra Andrew Hannah Alan Harkness Adrian Morley Davies * Miles Fisher * Spiros Polymeros Bjoern Groening Colin Petrie * with others

Summary Ambassador for Glasgow Cardiology Huge impact on British Heart Failure Cardiology Enormous contribution to European Heart Failure International “superstar” in Heart Failure Research

And…